Serratus Plane Block Versus Serratus Plane Block Plus Parasternal Block Combination for Breast Surgery

Serratus Plane Block Versus Serratus Plane Block Plus Parasternal Block on Postoperative Opioid Consumption and Dermatomal Analyses for Breast Surgery

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05911373

Enrollment

Registered

2023-06-22

Start date

2023-06-21

Completion date

2024-01-15

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Cancer, Breast

Brief summary

Mastectomy is a technique often used in breast cancer surgery. Patients experience moderate to severe pain postoperatively after this procedure. Various plane blocks, NSAIDs, and opioid analgesics can be administered to these patients as components of multimodal analgesia. In the the study, the investigators aimed to evaluate the analgesic effects of the serratus plane block, the parasternal block added to the serratus plane block, and the dermatomal differences.

Interventions

OTHERgroup serratus plan block

preoperativelly, Superficial Serratus Block performed with 30 ml %0.25 Bupivacaine and Parasternal Block performed with 10 ml saline

OTHERgroup serratus and parasternal plan block

preoperativelly, Superficial Serratus Block performed with 30 ml %0.25 Bupivacaine and Parasternal Block performed with 10 ml %0.25 Bupivacaine

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

1. American Society of Anesthesiologist's physiologic state I-III patients 2. To undergo Mastectomy Surgery 3. Being between the ages of 18-65 years

Exclusion criteria

* Having a known heart, kidney, liver or hematological disease * Having a history of peptic ulcer, gastrointestinal bleeding, allergy, chronic pain * Routine analgesic use and history of analgesic use in the last 24 hours * Not willing to participate in the study * Uncooperative patients who have coagulopathy or use anticoagulant drugs * To be allergic to one of the drugs to be used

Design outcomes

Primary

Measure	Time frame	Description
Postoperative opioid consumption	first 24 hours	First 24 hours total fentanyl consumption with patient controlled analgesia

Secondary

Measure	Time frame	Description
Visual analog pain score	First 24 hours	Post operative pain will be evaluated with a Visual Analogue Scale (between 0-10; 0: no pain, 10:worst pain) score
Sensory Assessment	24 hours	Sensory Assessment will be performed on patients following the block procedure with pinprick test.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026